What is the appropriate evaluation and management of hypoalbuminemia in a pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hypoalbuminemia in Pregnancy: Evaluation and Management

Understanding Physiological Changes

Hypoalbuminemia in pregnancy is a normal physiological finding that requires careful interpretation, not routine correction. During pregnancy, intravascular volume expansion causes hemodilution and reduces albumin concentration, with serum albumin levels typically decreasing to 33-34 g/L in the third trimester compared to 37 g/L in non-pregnant women 1. This physiological decrease reflects increased plasma volume rather than true albumin deficiency 2.

Critical Measurement Considerations

  • Always measure albumin-corrected calcium or ionized calcium directly, as total calcium measurements are unreliable due to pregnancy-related hemodilution 2
  • Serum albumin naturally decreases during pregnancy due to:
    • Hemodilution from intravascular volume expansion 2
    • Increased distribution volume 2
    • PTH-related protein (PTHrP) and vitamin D metabolic changes 2

When to Investigate Further

Pathological Hypoalbuminemia Thresholds

Investigate when albumin falls below these levels:

  • < 30 g/L: Associated with increased risk of complications 3
  • < 25 g/L: Significantly increased risk of adverse outcomes 4
  • < 20 g/L: High risk of severe complications including thrombocytopenia, elevated liver enzymes, and severe proteinuria 5

Essential Evaluation Components

1. Assess for Preeclampsia 6, 5, 7

  • Measure 24-hour urine protein (albumin < 20 g/L strongly correlates with severe proteinuria > 2 g/day) 6, 5
  • Check blood pressure (hypoalbuminemia may indicate developing preeclampsia) 7
  • Monitor for HELLP syndrome risk (odds ratio 12 when albumin < 2.5 g/dL) 6
  • Evaluate liver enzymes and platelet count 5

2. Rule Out Nephrotic Syndrome 8

  • Measure urine albumin-to-creatinine ratio 8, 9
  • Check for severely increased albuminuria (≥ 300 mg/g or ≥ 30 mg/mmol) 8
  • Assess for edema and hyperlipidemia 8
  • Monitor serum creatinine and estimated GFR 10, 11

3. Evaluate Renal Function 10, 11

  • Baseline serum creatinine and estimated GFR 10, 11
  • Urine albumin-to-creatinine ratio 9, 11
  • Monitor for proteinuria > 190 mg/24h (associated with increased pregnancy-induced hypertension risk) 10

4. Screen for Malnutrition 3

  • Assess for significant weight loss (> 10% body weight within 6 months) 4
  • Evaluate for muscle wasting 4
  • Consider nutritional support if albumin < 2.5 g/dL with clinical malnutrition 4

Management Approach

Do NOT Routinely Administer IV Albumin

Albumin infusion is not recommended for correcting low serum albumin levels in pregnancy. 12 The evidence shows:

  • No improvement in patient-important outcomes with albumin administration 12
  • Hypoalbuminemia reflects underlying inflammation or pathology, not albumin deficiency 13
  • Correction requires treating the underlying cause, not albumin replacement 13

Treat Underlying Conditions

1. For Preeclampsia-Related Hypoalbuminemia 6, 5

  • Close monitoring every 2-4 weeks if albumin 20-30 g/L 2
  • Consider delivery timing based on gestational age and severity 6
  • Monitor for maternal complications: ascites, HELLP syndrome, perinatal mortality risk 6

2. For Nephropathy 10, 11

  • Regular renal function monitoring during pregnancy 11
  • Target blood pressure < 130/80 mmHg 11
  • Discontinue ACE inhibitors/ARBs immediately if pregnancy confirmed 11
  • Use safe alternatives: methyldopa, labetalol, diltiazem 11

3. For Nutritional Causes 3, 4

  • Enteral nutritional support if surgery can be delayed 7-10 days 4
  • Avoid IV albumin for nutritional repletion 12
  • Address underlying inflammation or sepsis 3

Monitoring Strategy

Frequency Based on Albumin Level

  • Albumin 25-30 g/L: Monitor every 3-4 weeks 2
  • Albumin 20-25 g/L: Monitor every 2-4 weeks 2
  • Albumin < 20 g/L: Close surveillance, consider delivery planning 5

Parameters to Track

  • Serum albumin with calcium correction 2
  • Blood pressure and proteinuria 10, 6
  • Liver enzymes and platelet count 5
  • Renal function (creatinine, eGFR) 10, 11
  • Fetal growth and well-being 6

Key Clinical Pitfalls

  • Do not treat physiological hypoalbuminemia (33-34 g/L in third trimester is normal) 1
  • Do not use albumin infusion to correct low levels 12
  • Do not ignore albumin < 20 g/L even without other preeclampsia criteria (may predict early-onset disease) 5
  • Do not measure total calcium alone - always use albumin-corrected or ionized calcium 2
  • Do not assume hypoalbuminemia equals malnutrition - it primarily reflects inflammation 13

References

Research

Study on Serum Albumin in Third Trimester of Pregnancy.

Mymensingh medical journal : MMJ, 2015

Guideline

prevention and management of sternal wound infections.

The Journal of thoracic and cardiovascular surgery, 2016

Research

Preeclampsia: should plasma albumin level be a criterion for severity?

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2011

Research

Clinical significance of serum albumin level in pregnancy-related hypertension.

The journal of obstetrics and gynaecology research, 2010

Research

Plasma albumin level as an indicator of severity of preeclampsia.

Clinical and experimental obstetrics & gynecology, 2004

Guideline

(12) management of diabetes in pregnancy.

Diabetes Care, 2015

Guideline

diabetes and pregnancy: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2013

Research

Hypoalbuminemia: Pathogenesis and Clinical Significance.

JPEN. Journal of parenteral and enteral nutrition, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.